NEW YORK, N.Y. – The following is a list of initial public offerings planned for the coming week. Sources include Renaissance Capital, Greenwich, CT (www.renaissancecapital.com) and SEC filings.
Week of November 18
500.com Ltd. – Shenzhen, China, 5.786 million American depositary shares, each representing 10 class A ordinary shares, priced $9 to $11, managed by Deutsche Bank. Proposed NYSE symbol WBAI. Business: The leading online sports lottery service provider in China.
GFI Software S.A. – Luxembourg, 6.1 million common shares, priced $12 to $14, managed by J.P. Morgan, Credit Suisse, and Jefferies. Proposed NYSE symbol GFIS. Business: Provides collaboration and IT management software to small and medium size businesses.
Navigator Holdings Ltd. – London, U.K., 11.3 million common shares, priced $17 to $19, managed by Jefferies, and Morgan Stanley. Proposed NYSE symbol NVGS. Business: Owns and operates the world’s largest fleet of handysize liquefied gas carriers.
Oxford Immunotec Global plc – Abington, U.K., 5.36 million ordinary shares, priced $13 to $15, managed by J.P. Morgan, and Piper Jaffray. Proposed Nasdaq symbol OXFD. Business: Sells diagnostic tests for latent tuberculosis infection.
Sungy Mobile Ltd. – Guangzhou, China, 7 million American depositary shares, each representing 6 class A ordinary shares, priced $9.50 to $11.50, managed by Credit Suisse and J.P. Morgan. Proposed Nasdaq symbol GOMO. Business: Provides applications and mobile platform development products and services.
TetraLogic Pharmaceuticals Corp. – Malvern, Pa., 6.43 million shares, priced $13 to $15, managed by Oppenheimer, Guggenheim, and Needham. Proposed Nasdaq symbol TLOG. Business: Developing small molecule therapeutics for the treatment of cancer.
Trevena Inc. – King of Prussia, Pa., 5.77 million shares, priced $12 to $14, managed by Barclays, and Jefferies. Proposed Nasdaq symbol TRVN. Business: Clinical-stage biotech developing treatments for acute heart failure.
Vince Holding Corp. – New York, 10 million shares, priced $17 to $19, managed by Goldman Sachs, Baird, and BofA Merrill Lynch. Proposed NYSE symbol VNCE. Business: High-end contemporary clothing line.
Vital Therapies Inc. – San Diego, 4.4 million shares, priced $16 to 418, managed by Credit Suisse, and William Blair. Proposed Nasdaq symbol VTL. Business: Clinical-stage biotech developing treatments for acute liver failure.
